About AF Hauser
AF Hauser is a Healthcare company based in Valparaiso (United States) founded in 1983 by Janet Hauser and Dave Hauser, and was acquired by Cedarburg Pharmaceuticals in May 2009. Distributor of generic pharmaceutical drugs. AF Hauser offers products and services including Tablets, Capsules, Injectables, Creams and Ointments, and Vaccines. Its focus areas include Pharmaceutical Distributors and Generic Drugs. Its legal entity is A.F. Hauser, Inc. Its competitors include Pfizer, AmerisourceBergen and Renee; 2 of its 3 listed competitors have raised funding.
Company details
AF Hauser was established in 1983 by co-founders Janet Hauser and Dave Hauser in Valparaiso, United States. Operations focus on the distribution of generic pharmaceutical drugs within the healthcare sector. Services include supply chain management for pharmaceuticals, serving various markets in the region. The company maintains a presence through its domain, hauserpharmaceutical.com, supporting wholesale and retail distribution needs.
- Headquarters Valparaiso, United States
- Founders Janet Hauser, Dave Hauser
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website hauserpharmaceutical.com
- Social LinkedIn
- Acquired by Cedarburg Pharmaceuticals (May 2009)
- Legal Name A.F. Hauser, Inc.
- Investors
- Acquired byCedarburg Pharmaceuticals
(May 2009)
Products & Services of AF Hauser
AF Hauser offers a comprehensive portfolio of products and services, including Tablets, Capsules, Injectables, Creams and Ointments, and Vaccines.
Oral medications in tablet form for human treatments
Encapsulated drugs for oral consumption
Medications administered via injection for various uses
Topical applications for skin treatments
Immunization products for preventive healthcare
Investors in AF Hauser
AF Hauser has secured backing from 1 investor. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug research and development services for rare diseases are provided. | 1998 | cedarburgpharma.com | Grafton, United States |
Investor details for AF Hauser
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AF Hauser
2 people are tracked at AF Hauser (2 in leadership).
| Name | Role | Group |
|---|---|---|
Janet Hauser | Co-Founder | Leadership |
Dave Hauser | Co-Founder | Leadership |
Complete people profiles for AF Hauser
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AF Hauser
2 dated milestones of AF Hauser across 26 years, from founding to its latest funding, stage changes and deals.
- Founded AF Hauser is founded.
- Exit Acquired by Cedarburg Pharmaceuticals.
Competitors of AF Hauser
AF Hauser has 3 listed competitors in our database, 2 of them funded. They include Pfizer, AmerisourceBergen and Renee.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| amerisourcebergen.com | 1985 | Chesterbrook, United States | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | ||
| renee.com | 2021 | Los Angeles, United States | $8.2M | Diversified drugs are distributed by Renee in the United States. |
Detailed competitors of AF Hauser
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AF Hauser
The website of AF Hauser (hauserpharmaceutical.com) receives about 1.9K visits a month and ranks #8,413,504 among all websites worldwide, #7,364 in Biotechnology and Pharmaceuticals.
- Monthly visits1.9K
▲ 14.2% vs previous month
- Global rank#8,413,504
among all websites
- Category rank#7,364
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit2.2
- Average visit47 sec
- DevicesDesktop 35% Β· Mobile 65%
Websites whose visitors overlap most with AF Hauser. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
globalphar.com | globalphar.com | 100% | β | ||
diabeticproducts.com | diabeticproducts.com | 100% | β | ||
| genzyme.com | 100% | View details | |||
| endo.com | 100% | 10K | #2,323,439 | View details | |
hemispherx.net | hemispherx.net | 100% | #13,055,489 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for AF Hauser
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as AF Hauser (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Af Hauser
Complete news archive for AF Hauser
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AF Hauser
AF Hauser was founded in 1983.
AF Hauser is headquartered in Valparaiso, United States. It is registered at Valparaiso, Indiana, United States.
AF Hauser was established in 1983 by co-founders Janet Hauser and Dave Hauser in Valparaiso, United States. Operations focus on the distribution of generic pharmaceutical drugs within the healthcare sector. Services include supply chain management for pharmaceuticals, serving various markets in the region. The company maintains a presence through its domain, hauserpharmaceutical.com, supporting wholesale and retail distribution needs.
AF Hauser's top competitors include Pfizer, AmerisourceBergen and Renee.
AF Hauser offers Tablets, Capsules, Injectables, Creams and Ointments, and Vaccines.
AF Hauser has 1 investor. Key investors include Curia.
AF Hauser operates through A.F. Hauser, Inc..
Yes. AF Hauser was acquired by Cedarburg Pharmaceuticals in May 2009.

